A share price of Terns Pharmaceuticals Inc [TERN] is currently trading at $17.43, up 24.23%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TERN shares have gain 102.91% over the last week, with a monthly amount glided 106.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Terns Pharmaceuticals Inc [NASDAQ: TERN] stock has seen the most recent analyst activity on November 04, 2025, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $20 for it. Previously, William Blair upgraded its rating to Outperform on November 03, 2025. On October 15, 2025, Truist initiated with a Buy rating and assigned a price target of $20 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $15 on September 17, 2025. In a note dated October 31, 2024, Oppenheimer initiated an Outperform rating and provided a target price of $82 on this stock.
Terns Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $1.87 and $16.27. Currently, Wall Street analysts expect the stock to reach $22.5 within the next 12 months. Terns Pharmaceuticals Inc [NASDAQ: TERN] shares were valued at $17.43 at the most recent close of the market. An investor can expect a potential return of 29.09% based on the average TERN price forecast.
Analyzing the TERN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.27 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.70 points at the first support level, and at 13.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.95, and for the 2nd resistance point, it is at 20.48.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Terns Pharmaceuticals Inc [NASDAQ:TERN] is 24.70. Also, the Quick Ratio is 24.70, while the Cash Ratio stands at 11.3.
Transactions by insiders
Recent insider trading involved JILL QUIGLEY, Director, that happened on Nov 04 ’25 when 24520.0 shares were purchased. Chief Medical Officer, Kuriakose Emil completed a deal on Oct 01 ’25 to sell 944.0 shares. Meanwhile, Chief Medical Officer Kuriakose Emil sold 853.0 shares on Jul 01 ’25.
